Question: Washington Subscriber Answer: Effective for dates of service on or after Nov. 10, 2009, Medicare has an updated national coverage determination (NCD) for FDG PET imaging for cervical cancer. Medicare has ended the coverage with evidence development (CED) requirements for initial staging for initial treatment. Medicare will cover one FDG PET for cervical cancer. That one exam must meet specific requirements: • The exam must be for staging (not initial diagnosis). • The patient must have biopsy proven cervical cancer. • The treating physician must need the study to determine the tumor's exact location, extent, or both for the following therapeutic purposes related to initial treatment strategy: • To determine whether the beneficiary is a candidate for an invasive diagnostic or therapeutic procedure; or • To determine the optimal anatomic location for an invasive procedure; or • To determine the tumor's anatomic extent when the recommended anti-tumor treatment depends on the tumor's extent. Your claim must include all of the following for reimbursement: • An appropriate CPT code from 78608 (Brain imaging, positron emission tomography [PET]; metabolic evaluation), 78811-78813 (Positron emission tomography [PET] imaging ...), and 78814-78816 (Positron emission tomography (PET) with concurrently acquired computed tomography [CT] for attenuation correction and anatomical localization imaging ...) • Modifier PI (PET Tumor initial treatment strategy) • A cervical cancer diagnosis code (such as 180.x, Malignant neoplasm of cervix uteri). Action step: Resources: